修改释放的3D打印囊含有基托的自纳米乳化系统,用于个性化医疗应用
Bahaa Shaqour1,2, Hiba Natsheh2,3, Naim Kittana2,4
1Mechanical and Mechatronics Engineering Department, Faculty of Engineering and Information Technology, An-Najah National University, P.O. Box 7, Nablus P4110257, Palestine.
ACS biomaterials science & engineering
|May 15, 2024
概括
个性化医学在3D打印的囊中取得了进步,用于定制的甲释放. 新型药物输送系统和聚合物组合增强了药物的疗效和受控释放.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
- 生物医学工程 生物医学工程
背景情况:
- 个性化医疗需要先进的药物输送系统来为特定患者提供治疗.
- 3D打印为创建定制剂型提供了一个有前途的平台.
- 控制药物释放对于优化治疗结果和最大限度地减少副作用至关重要.
研究的目的:
- 为了研究3D打印的肠道囊,以提供个性化的烯.
- 通过使用基甲基纤维素甲酸:聚乙烯糖醇 (HPMCP:PEG) 和聚乙烯醇 (PVA) 聚合物来探索改性药物释放.
- 开发和评估一种新的托载自纳米乳化药物输送系统 (SNEDDS),用于囊填充.
主要方法:
- 使用HPMCP3D打印囊的制造:PEG和PVA通过热挤出.
- 导线热和机械性能的表征.
- 在体外释放药物的研究和评估二在SNEDDS中的COX-2抑制活性.
主要成果:
- 根据聚合物类型和囊厚度显示可调节的烯释放.
- 成功开发并描述了基于石榴种子油的SNEDDS,用于.
- 在SNEDDS中加载时观察到托在体外增强的COX-2抑制活性.
结论:
- 3D打印有助于开发针对患者的药物输送系统.
- 量身定制的聚合物配方能够精确控制药物释放特征.
- 纳入SNEDDS可以增强模范药物的治疗潜力,如二.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...


